An Open-label, Randomized, 2x4 Crossover Study to Compare the Pharmacokinetics and Safety Following Administration of DWJ1568 and DWC202215 in Healthy Volunteers
Latest Information Update: 10 Nov 2023
At a glance
- Drugs DWJ 1568 (Primary)
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Daewoong Pharmaceutical
Most Recent Events
- 10 Nov 2023 New trial record